Medical Directive. July 1, 2011 Review due by: December 1, Medical Director: Date Revised: December 1, 2017

Similar documents
Medical Directive. Title: Injection of Vitamin B12 Number: HFHT 17. Activation Date: May 1, 2016 Review due by: May 1, 2018

PATIENT GROUP DIRECTION (PGD) FOR

Croydon Health Services NHS Trust (Working in Partnership) Shared Care Guideline: Prescribing Agreement

Using Practitioner Supply Orders and Standing Orders in the Rheumatic Fever Prevention Programme. Guidance for sore throat management services

Primary Care practice clinics within the Edmonton Southside Primary Care Network.

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM

Antimicrobial Stewardship in Continuing Care. Nursing Home Acquired Pneumonia Clinical Checklist

Valparaiso University Student Health Center lmmunotherapy Check List for Allergy patients

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CYTARABINE CONTINUOUS INFUSION

An evaluation of the management of patients with sore throats by practice nurses and GPs

Piedmont Access to Health Services. Standing Orders for Patient Work-ups

Sore Throat Test & Treat Service. NHS Innovation Accelerator

CRAIG HOSPITAL POLICY/PROCEDURE

Oral Ibrutinib (single agent)

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FMD. Patient s first names.

NEW EMPLOYEE HEALTH PLAN BENEFIT. Care When You. Need

Illustrative Pathways to Self Care

PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM WEEKLY RITUXIMAB. Patient s first names. Date of birth

Clear Creek ISD FFAD (REGULATION) Students: Communicable Disease Control

Consultation Group: See relevant page in the PGD. Review Date: October 2015

City. Whom may we thank for referring you to us?

Title Protocol for the Management of Chest Wall Injuries (over 12 years of age) in MIU s and WIC s.

Clinical Guidance on the Identification and Evaluation of Possible SARS-CoV Disease among Persons Presenting with Community-Acquired Illness Version 2

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES

Protocol Applies To: UW Health Clinics: all adult outpatients with an active order for warfarin

Lab Forms & Throat Swabs Bradley O'Donnell R/N,PGDip & Karen Clarke R/N, PG Cert

STANDARDIZED PROCEDURE HEPATIC ARTERY INFUSION OF CHEMOTHERAPY (Adults, Peds)

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PAZOPANIB. Patient s first names.

Patient Information Form

CMS Mega Rule: Implications for Pharmacists and Pharmacies

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Medication Policy. Linked to National Quality Standards- Quality Area Two: Element Policy statement

Medicine Management Policy

Welcome- August 21, 2018 Lunch & Learn: Ensuring Accuracy of Standing Orders

This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.

Azathioprine. Shared Care Agreement for the treatment of Ulcerative colitis and Crohn s disease with Azathioprine, March 2012 Page 1 of 6

Last Name First Middle. Mailing Address. City State Zip Phone. Date of Birth Age Soc. Sec# Cell. Employer Work Phone

LPN 8 Hour Didactic IV Education

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Report on a QI Project Eligible for Part IV MOC

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Impact of Retail Clinics on Quality & Costs

STANDING ORDERS FOR THE MANAGEMENT OF WARFARIN Dose adjustment and INR testing frequency Applicable to: Pharmacists. Issued by: Contact:

ALASKA COMMUNITY HEALTH AIDE/PRACTITIONER PROGRAM Standing Orders

Martina Khundakar - Senior Clinical Pharmacist Teresa Barnes - Lead Clinical Pharmacist - Specialist Care. Timothy Donaldson, Trust Chief Pharmacist

Provider newsletter. Dental Home Program launches for member s age 0 6

Shoulder or Elbow Surgery

Newfoundland and Labrador Pharmacy Board

Adverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN

Medicine Protocol for the Administration of Inactivated Influenza Vaccine (Split Virion) BP Version 1, June 2017

STANDARDIZED PROCEDURE INTRAVENTRICULAR CHEMOTHERAPY VIA OMMAYA RESERVOIR (Adult, Peds)

STANDARDIZED PROCEDURE INFRARED COAGULATION THERAPY (Adults, Peds)

The most up to date version of this policy can be viewed at the following website:

INFORMATION FOR PATIENTS

Paediatric Pharmaceutical Care: Internships and Placements

Hematology Team. Name: Your JCC Chart #:

Adventure Club. Before and After School Care Enrollment Packet. Before and After School Care Mission:

Reducing Warfarin ADR s with a Nurse Led Anticoagulation Clinic: A New Model of Patient Care

Assistance With Self- Administered Medication. 2-hour Update Training

STUDENT-OVER THE COUNTER MEDICATIONS FORM SUMMER 2016

PAYMENT IS REQUIRED AT THE TIME SERVICES ARE RENDERED. THANK YOU!

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CHOP 21 + RITUXIMAB

A Commercial HMO Plan

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX)

Benefits That Benefit You

International School Bangkok Instructions for Completion of Returning Students Medical Package

This matter was initiated by a letter from the complainant received on March 20, A response from Dr. Justin Clark was received on May 11, 2017.

2200 Northern Boulevard, Suite 133 East Hills, NY Fax (516) Transitional Care

PATIENT INFORMATION. Patient name: Date of birth: Sex: Age: Home address: City: State: Zip: Billing address (if different): City: State: Zip:

The Ins and Outs of Point-of- Care Testing

Community Pharmacy: local healthcare. Gill Hall Service Development Office South Staffs LPC

Drug Therapy Management

Cyclophosphamide INFUSION Infusion 4 Plus

Felpham Community College Medical Conditions in School Policy

PATIENT AGREEMENT TO SYSTEMIC THERAPY: GENERIC CONSENT FORM. Patient s first names. Date of birth. Job title

Health Professions Council of South Africa Medical and Dental Professions Board

For more information on any of the topics covered, please visit our provider self-service website at

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM DOCETAXEL + PREDNISOLONE. Patient s first names

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

NewsBrief. AvMed Network. Administrative Updates. Health & Medical. What's News. Medicare Annual Enrollment. Member Experience Surveys

ADMINISTRATION OF MEDICATION BY DELEGATION

Patient identifier/label: Page 1 of 5 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM IMATINIB. Patient s first names.

Stage 2 GP longitudinal placement learning outcomes

LESSON SIX. Skin, Eyes, Ears, Nose and Throat Assessment

Patient Group Direction for ACICLOVIR (Version 02) Valid From 1 October September 2019

Reviewing regulatory requirements for top ten federal Nursing Home Tags issued in Minnesota. Eva Loch, MDH Nursing Evaluator

College of Sequoias Physical Therapist Assistant Program Student Health Release Form

A Changing Landscape Regulatory Impact on Medication Management

Health Professions Council of South Africa Medical and Dental Professions Board

COLON & RECTAL SURGERY, INC.

Independent investigation into the death of Mr John Lomas a prisoner at HMP Whatton on 20 April 2017

SASKATCHEWAN ASSOCIATIO

PREOPERATIVE PATIENT QUESTIONAIRE

Administering Medicine Policy

The Urine Dipstick: A Quick Way To Over-Treat! Ann McFeeters, RN Infection Control Practitioner September 26, 2012

Transcription:

Medical Directive Assessment and Treatment of Pharyngitis in Adults (>15 yo) Assigned Number: 013 Activation Date: July 1, 2011 Review due by: December 1, 2019 Approval Signature & Date Medical Director: Date Revised: December 1, 2017 Executive Director: Date Revised: _December 1, 2017 Implementers and Authorizers required to review and refresh signatures due to clinical revisions. Order and/or Delegated Procedure: Appendix Attached: Yes No Assessment for and treatment of Pharyngitis in Adults (> 15 yo) by Registered Nurses, in person. Recipient Patients: Appendix Attached: Yes No Appendix 2 - Authorizer Approval Form All active adult patients (>15 yo) of the Thames Valley FHT physicians, identified on the attached Authorizer Approval Form (Appendix 2), who require assessment for and treatment of Pharyngitis. Authorized Implementers: Appendix Attached: Yes No Appendix 1 - Implementer Approval Form Appendix 8 - Implementer Performance Readiness Form Thames Valley FHT Registered Nurses (RN) * * The implementing RN must receive orientation from the authorizing physician, with regards to the task. The RN and authorizing physician must sign the Implementer Performance Readiness Form (Appendix 8) after successful completion of the orientation. Following review of this directive the Implementer Approval Form (Appendix 1) must be signed by the RN indicating acceptance of this medical directive. Medical Directive 013 - Assessment and Treatment of Pharyngitis in Adults (>15yo) Page 1

Indications: Appendix Attached: Yes No Appendix 11 - Order Treatment Table For Pharyngitis in Adults >15 yo 1. Verbal consent received from the patient/substitute decision maker for the implementing RN to assess and treat the Pharyngitis 2. The primary purpose of treatment is the prevention of acute rheumatic fever. 3. Patient symptoms consistent with Pharyngitis *: After a clinical assessment, where you conclude the patient has an uncomplicated upper respiratory tract infection with a sore throat, determine the patient s total sore throat score by assigning points according to the following criteria: Step 1 Criteria Points Temperature > 38 C 1 Absence of Cough 1 Swollen, tender anterior cervical nodes 1 Tonsillar swelling or exudates 1 Age 15-44 0 Age > 45-1 Step 2 Choose the appropriate management according to the sore throat score: Total Score Risk of Strep Infection % Suggested Management 0 or less 1 2.5 No culture or antibiotic required 1 5 10 ----------------------------------------------------------------------------------------------------------------------------------- 2 11-17 Perform culture OR office Rapid antigen test (not both) 3 28-35 Treat only if test is positive for Group A Strep ----------------------------------------------------------------------------------------------------------------------------------- 4 or more 51-53 Start antibiotic therapy on clinical grounds (patient has high fever or is clinically unwell and presents early in the disease course) If culture (or office Rapid antigen test) is performed and the result is negative then antibiotics should be discontinued or not initiated Note: 80-90% of the time, uncomplicated pharyngitis is NOT a Group A Streptococcal infection (i.e., Strep Throat) and does NOT require antibiotic therapy. For treatment of Pharyngitis refer to the attached Order Treatment Table for Pharyngitis in the Adult > 15 yo (Appendix 11) * Anti-Infective Guidelines for Community Acquired Infections 2016 Edition Medical Directive 013 - Assessment and Treatment of Pharyngitis in Adults (>15yo) Page 2

Contraindications: 1. No verbal consent from patient/substitute decision maker for RN to implement this medical directive. 2. Patient is < 15 years old (see separate Medical Directive for Treatment of Pharyngitis in Children) 3. Abnormal liver or kidney function (AST, ALP, Bilirubin, egfr, Creatinine). 4. Multiple (2 or more) medications. 5. Blood thinning medications (eg. Warfarin, Heparin, Plavix, New Oral Anticoagulants (NOAC s) ) For these patients the symptoms are reviewed and documented by the RN. The RN then books the patient for an urgent appointment with the physician and/or consults with the physician for further direction on patient care: in a timely manner as per usual practice with urgent calls. Consent: Appendix Attached: Yes No 1. Patients of Thames Valley FHT family physicians 2. RN obtains verbal patient/substitute decision maker consent prior to the implementation of care Guidelines for Implementing the Order/ Procedure: Appendix Attached: Yes No Appendix 11 - Order Treatment Table for Pharyngitis in the Adult > 15 yo For assessment and treatment of patients who meet the Indications described above: The RN assesses the patient for symptoms of Pharyngitis according to the symptoms in Indications The RN documents the assessment in the EMR as per usual documentation* The RN assesses the patient for allergies to previously used preparations, documents in the EMR any previously undocumented allergies. The RN will advise the patient/substitute decision maker to treat Pharyngitis according to the attached Order Treatment Table (for Pharyngitis in Adult > 15 yo (Appendix 11). A prescription is provided as per usual standard with the family physician or on-call physician s name on the prescription. Prior to prescribing, ensure that the patient has normal liver and kidney function (AST, ALP, Bilirubin, egfr, Creatinine). If there are no results on the chart over the past 12 months, the patient should be asked if they were ever told that they have abnormal kidney or liver function. Prior to prescribing an antibiotic, ensure that the patient is not taking any other medications that may interact with an antibiotic, in particular blood thinning products (eg. Warfarin, Heparin, Plavix, New Oral Anticoagulants (NOAC s). The RN advises the patient/substitute decision maker that if symptoms do not resolve within a few days to set up an appointment with a physician. * Potter, P.A. & Perry, A.G. (2006). Fundamentals of Nursing. St. Louis: Mosby. College of Nurses of Ontario (2008). CNO Practice Standard: Documentation Medical Directive 013 - Assessment and Treatment of Pharyngitis in Adults (>15yo) Page 3

Documentation and Communication: Appendix Attached: Yes No 1. Documentation in the patient s medical record needs to include: name and number of the directive, name of the implementer (including credential), and name of the physician/authorizer responsible for the directive and patient. 2. Information regarding implementation of the procedure and the patient s response should be documented, in the patient s medical record, in accordance with standard documentation practice. 3. Standard documentation is recommended for prescriptions, requisitions, and requests for consultation.* * Potter, P.A. & Perry, A.G. (2006). Fundamentals of Nursing. St. Louis: Mosby. College of Nurses of Ontario (2008). CNO Practice Standard: Documentation Review and Quality Monitoring Guidelines: Appendix Attached: Yes No 1. The Directive remains in force until and unless amendment occurs. Review will occur biennially or if the following situations occur. In the case the Medical Director identifies the need to change the Medical Directive, at least one TVFHT member of the implementing discipline will be consulted. 2. At any such time that issues related to the use of this directive are identified, the team must act upon the concerns immediately by identifying these concerns to the Medical Director. The Medical Director will review these concerns and consult with at least one TVFHT member of the implementing discipline, before necessary changes are made. 3. If new information becomes available between routine renewals, such as the publishing of new Anti Infective Guidelines for Community Acquired Infections, and particularly if this new information has implications for unexpected outcomes, the directive will be reviewed by the Medical Director of the TVFHT and a minimum of one implementing RN. Approving Physician(s)/Authorizer(s): Appendix Attached: Yes No Appendix 2 - Authorizer Approval Form TVFHT Family Physician Authorizer Approval Form (Appendix 2) Medical Directive 013 - Assessment and Treatment of Pharyngitis in Adults (>15yo) Page 4

Appendix 11: Pharyngitis Order Treatment Table for Adults > 15 yo Adults 15 years old Viral 80-90% of the time Pharyngitis is NOT bacterial NO Antibiotic OR Antiviral Treatment indicated Viral features include: Conjunctivitis, cough, hoarseness, coryza, anterior stomatitis, discrete ulcerative lesions Treatment 10 days Bacterial Group A Strep First Line: Penicillin V 300 mg (500.000 Units) tid OR 600 mg bid Second Line: Erythromy cin 250 mg qid Third Line: 250 mg qid Cephalexin 500 mg bid Cefadroxil Cefuroxim e Cefprozil Clarithrom ycin 500 mg day 1 250 mg day 2-5 Azithromy cin *Anti-Infective Guidelines for Community Acquired Infections 2016 Edition